These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38370683)

  • 21. Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites.
    Swearingen KE; Lindner SE; Flannery EL; Vaughan AM; Morrison RD; Patrapuvich R; Koepfli C; Muller I; Jex A; Moritz RL; Kappe SHI; Sattabongkot J; Mikolajczak SA
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005791. PubMed ID: 28759593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium vivax: sequence polymorphism and effect of natural selection at apical membrane antigen 1 (PvAMA1) among Indian population.
    Thakur A; Alam MT; Bora H; Kaur P; Sharma YD
    Gene; 2008 Aug; 419(1-2):35-42. PubMed ID: 18547744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response.
    Bittencourt NC; Silva ABIED; Virgili NS; Schappo AP; Gervásio JHDB; Pimenta TS; Kujbida Junior MA; Ventura AMRS; Libonati RMF; Silva-Filho JL; Dos Santos HG; Lopes SCP; Lacerda MVG; Machado RLD; Costa FTM; Albrecht L
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008471. PubMed ID: 32639964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.
    Chattopadhyay R; Velmurugan S; Chakiath C; Andrews Donkor L; Milhous W; Barnwell JW; Collins WE; Hoffman SL
    PLoS One; 2010 Dec; 5(12):e14275. PubMed ID: 21151554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-ligand and parasite protein-protein interactions in Plasmodium vivax: Analysing rhoptry neck proteins 2 and 4.
    Bermúdez M; Arévalo-Pinzón G; Rubio L; Chaloin O; Muller S; Curtidor H; Patarroyo MA
    Cell Microbiol; 2018 Jul; 20(7):e12835. PubMed ID: 29488316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
    Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
    Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.
    Harris KS; Casey JL; Coley AM; Masciantonio R; Sabo JK; Keizer DW; Lee EF; McMahon A; Norton RS; Anders RF; Foley M
    Infect Immun; 2005 Oct; 73(10):6981-9. PubMed ID: 16177378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1.
    Guy AJ; Irani V; Richards JS; Ramsland PA
    Malar J; 2018 May; 17(1):183. PubMed ID: 29720179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1).
    Arnott A; Mueller I; Ramsland PA; Siba PM; Reeder JC; Barry AE
    PLoS Negl Trop Dis; 2013; 7(10):e2506. PubMed ID: 24205419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.
    Schafer C; Dambrauskas N; Steel RW; Carbonetti S; Chuenchob V; Flannery EL; Vigdorovich V; Oliver BG; Roobsoong W; Maher SP; Kyle D; Sattabongkot J; Kappe SHI; Mikolajczak SA; Sather DN
    Malar J; 2018 Oct; 17(1):370. PubMed ID: 30333026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission.
    Arnott A; Wapling J; Mueller I; Ramsland PA; Siba PM; Reeder JC; Barry AE
    Malar J; 2014 Jun; 13():233. PubMed ID: 24930015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion.
    Srinivasan P; Beatty WL; Diouf A; Herrera R; Ambroggio X; Moch JK; Tyler JS; Narum DL; Pierce SK; Boothroyd JC; Haynes JD; Miller LH
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13275-80. PubMed ID: 21788485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
    Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
    Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.
    Charoenvit Y; Mellouk S; Sedegah M; Toyoshima T; Leef MF; De la Vega P; Beaudoin RL; Aikawa M; Fallarme V; Hoffman SL
    Exp Parasitol; 1995 May; 80(3):419-29. PubMed ID: 7729477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax.
    Sattabongkot J; Yimamnuaychoke N; Leelaudomlipi S; Rasameesoraj M; Jenwithisuk R; Coleman RE; Udomsangpetch R; Cui L; Brewer TG
    Am J Trop Med Hyg; 2006 May; 74(5):708-15. PubMed ID: 16687667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional antibodies against
    Barry A; Behet MC; Nébié I; Lanke K; Grignard L; Ouedraogo A; Soulama I; Drakeley C; Sauerwein R; Bolscher JM; Dechering KJ; Bousema T; Tiono AB; Gonçalves BP
    Wellcome Open Res; 2018; 3():159. PubMed ID: 30828645
    [No Abstract]   [Full Text] [Related]  

  • 38. Low levels of polymorphisms and no evidence for diversifying selection on the Plasmodium knowlesi Apical Membrane Antigen 1 gene.
    Faber BW; Abdul Kadir K; Rodriguez-Garcia R; Remarque EJ; Saul FA; Vulliez-Le Normand B; Bentley GA; Kocken CH; Singh B
    PLoS One; 2015; 10(4):e0124400. PubMed ID: 25881166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional insights into the malaria parasite moving junction complex.
    Vulliez-Le Normand B; Tonkin ML; Lamarque MH; Langer S; Hoos S; Roques M; Saul FA; Faber BW; Bentley GA; Boulanger MJ; Lebrun M
    PLoS Pathog; 2012; 8(6):e1002755. PubMed ID: 22737069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
    Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.